MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

21st International Congress » Surgical Therapy: Parkinson’s Disease

Date: Monday, June 5, 2017

Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Meeting: 21st International Congress

1:45pm-3:15pm
A Novel Deep Brain Stimulation Programming Paradigm for Parkinson’s disease

J. Karl, L. Verhagen, D. Ocegueda (Chicago, IL, USA)

1:45pm-3:15pm
Action tremor control with deep brain stimulation in patients with Parkinson’s disease: Specific target associations

K. Nozile-Firth, V. Viswanathan, K. Foote, M. Okun, A. Wagle Shukla (Gainesville, FL, USA)

1:45pm-3:15pm
Advanced DBS programming – Multiple Groups :  3yrs experience

g. hosurkar, r. gopalakrishnan (Bengaluru, karnataka, India)

1:45pm-3:15pm
An Objective Tool to Guide Target Selection for DBS in PD (GPi vs STN)

L. Meytin, T.-W. Liang (Philadelphia, PA, USA)

1:45pm-3:15pm
Analysis of the exclusion causes for deep brain stimulation in Parkinson’s Disease Center in southern Taiwan

Y.-F. CHEN, Y.-F. CHEN, C.-C. CHANG, Y. LI, Y.-Y. CHANG (Kaohsiung, Taiwan)

1:45pm-3:15pm
Asymptomatic and transitory postoperative hypodense lesion around deep brain stimulation electrode

M. Sousa, F. Moreira, N. Canário, O. Brito, R. Pereira, M. Rito, C. Januário (Coimbra, Portugal)

1:45pm-3:15pm
Automated DBS Contact Selection using Coherence in Parkinson’s Disease

J. van Zijl, J. Elting, T. van Laar, F. Lange, G. Drost, D. Oterdoom, J. van Dijk, M. Tijssen, M. Beudel (Groningen, Netherlands)

1:45pm-3:15pm
Automatic discrimination between the striatum, Globus pallidus externa and Globus pallidus interna during deep brain stimulation surgery

D. Valsky, H. Bergman, Z. Israel (Jerusalem, Israel)

1:45pm-3:15pm
Baseline characteristics associated with greatest improvement in HRQL after DBS surgery

P. Schmidt, F. Cubillos, C. Martinez-Rubio, K. Lyons, C. Marras, T. Davis, E. Nelson, M. Okun (Miami, FL, USA)

1:45pm-3:15pm
Battery consumption and need for replacement in patients with Parkinson disease treated with interleaved deep brain stimulation

L. Deuel, J. Pilitsis, A. Ramirez-Zamora (Albany, NY, USA)

1:45pm-3:15pm
Clinical utility of chronic directional subthalamic Deep Brain Stimulatoin in Parkinson’s Disease

C. Hartmann, L. Venkatesan, P. Slotty, J. Vesper, A. Schnitzler (Düsseldorf, Germany)

1:45pm-3:15pm
Cognitive effects of GPi versus STN deep brain stimulation in Parkinson’s Disease: experience with patients with moderate cognitive impairment

C. Marques-Matos, C. Sousa, J. Lima, P. Monteiro, P. Linhares, R. Vaz, M.J. Rosas (Porto, Portugal)

1:45pm-3:15pm
Cognitive safety of eight-hours adaptive deep brain stimulation (aDBS) in Parkinson’s disease

R. Ferrucci, F. Ruggiero, F. Cortese, T. Bocci, M. Rosa, M. Arlotti, M. Colombo, S. Marceglia, F. Mameli, F. Cogiamanian, G. Ardolino, M. Locatelli, P. Rampini, A. Priori (Milan, Italy)

1:45pm-3:15pm
Combined Surgical Therapies for Optimal Management of Advanced Parkinson’s Disease

L. Kirkpatrick, Y. Torres-Yaghi, A. Keys, N. Starr, T. Kimbason, C. Moussa, F. Amjad, F. Pagan (Washington, DC, USA)

1:45pm-3:15pm
Comparison of lead localization in postoperative CT versus MRI

R. Nickl, M. Reich, P. Fricke, F. Steigerwald, F. Lange, R.-I. Ernestus, J. Volkmann, C. Matthies (Würzburg, Germany)

1:45pm-3:15pm
Comparison of neuropathology in Parkinson’s disease subjects with and without deep brain stimulation

G. Pal, B. Ouyang, G. Serrano, H. Shill, C. Goetz, G. Stebbins, L. Metman, E. Driver-Dunckley, S. Mehta, J. Caviness, M. Sabbagh, C. Adler, T. Beach (Chicago, IL, USA)

1:45pm-3:15pm
Comparison of pallidal and subthalamic deep brain stimulation in Parkinson’s disease: therapeutic and adverse effects

H.-S. Ryu, M.-S.K. Kim, S. You, M.-J.K. Kim, Y.J. Kim, J. Kim, K. Kim, S.J. Chung (Seoul, Republic of Korea)

1:45pm-3:15pm
Comparison of subthalamic and pallidal deep brain stimulation in treatment of Parkinson’s disease: a 5-year follow-up study

A. Gamaleya, A. Tomskiy, A. Dekopov, E. Bril, A. Poddubskaya, N. Fedorova, V. Shabalov (Moscow, Russian Federation)

1:45pm-3:15pm
Contact location and non-motor outcomes in subthalamic nucleus deep brain stimulation for Parkinson’s disease

D. Floden, C. Matias, C. Wathen, G. Ozinga, O. Hogue, A. Machado (Cleveland, OH, USA)

1:45pm-3:15pm
Correspondence between MRI borders of the subthalamic nucleus and its electrophysiological borders: a comparison study using intraoperative CT.

S. Bus, P. Van den Munckhof, M. Bot, G. Pal, B. Ouyang, S. Sani, L. Verhagen-Metman (Chicago, IL, USA)

1:45pm-3:15pm
Deep brain recording and surgical time in stereotactic and functional neurosurgery for movement disorders

J. Teijeiro Amador, R. Macías, C. Maragoto, N. Quintanal (Havana, Cuba)

1:45pm-3:15pm
Deep Brain Stimulation (DBS) for Parkinson Disease in the Philippines: Outcomes and Practice of the First DBS Center

J.D. Diestro, T. Vesagas, J. Aguilar, R. Teleg, J. Anlacan, R.D. Jamora (Manila, Philippines)

1:45pm-3:15pm
Deep Brain Stimulation for Parkinson Disease before L-dopa treatment: experience in three cases.

d. servello, M. Porta, e. zekaj (Milano, Italy)

1:45pm-3:15pm
Deep Brain Stimulation for Parkinson’s disease: Short-term outcomes, referral patterns and health disparities.

D. Di Luca, V. Aldahondo, W. Jermakowicks, L. Segala, H. Moore, C. Singer, B. Levin, J. Jagid, C. Luca (Miami, FL, USA)

1:45pm-3:15pm
Deep brain stimulation influences on event-related potentials (P300) in Parkinson’s disease

M. Zibetti, S. Palermo, S. Vighetti, A. Romagnolo, L. Lopiano (Torino, Italy)

1:45pm-3:15pm
Degree, onset and longevity of benefit achieved with Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) as assessed by the UPDRS.

D. Caputo, O. Mark, D. Schneider, R. DiPaola, S. Danish, E. Hargreaves (New Brunswick, NJ, USA)

1:45pm-3:15pm
Directional distribution of subthalamic nucleus beta activity in patients with Parkinson’s disease

G. Tinkhauser, A. Pogosyan, I. Debove, A. Nowacki, H. Tan, K. Petermann, K. Seidel, M. Oertel, C. Pollo, P. Brown, M. Schuepbach (Oxford, United Kingdom)

1:45pm-3:15pm
Disparities in Access to DBS Surgery Based on Demographics of Patients with PD Admitted for DBS Surgery in the United States from 2003 to 2013

F.S. Benesh, S. Gupta, V. Sung (Birmingham, AL, USA)

1:45pm-3:15pm
Displacement of deep brain stimulation (DBS) lead location after implantation: Preliminary result of a study comparing early Vs late CT findings

X.-L. Zhu, C. Lau, C.-M. Cheung, D. Chan, A. Chan, V. Mok, J. Yeung, W. Poon (Hong Kong, China)

1:45pm-3:15pm
Dynamic of symptoms of dopamine dysregulation syndrome after deep brain stimulation in patients with Parkinson`s disease

S. Omarova, N. Fedorova, A. Tomskiy, A. Gamaleya, E. Bril, N. Gubareva (Moscow, Russian Federation)

1:45pm-3:15pm
Dynamics of subthalamic nucleus beta bursts in Parkinson’s disease during ON and OFF dopaminergic state

G. Tinkhauser, A. Pogosyan, H. Tan, A. Kühn, P. Brown (Oxford, United Kingdom)

1:45pm-3:15pm
Effect of bilateral subthalamic nucleus deep brain stimulation on quality of life in advanced Parkinson’s disease patients

s. tandra, B. ramavath, r.m. kandadai, r. borgohain (hyderabad, India)

1:45pm-3:15pm
Effect of deep brain stimulation of the subthalamic nucleus on cranial tremor in Parkinson’s disease

L. Cameron, C. Kilbane, A. Shaikh (Cleveland, OH, USA)

1:45pm-3:15pm
Effects of deep brain stimulation in genetic parkinsonism

L. Oliveira, R. Cury, E. Barbosa (Sao Paulo, Brazil)

1:45pm-3:15pm
Effects of deep brain stimulation on olfactory function in Parkinson’s disease

R. Cury, M. Carvalho, M.g. Santos Ghilardi, A. Estevo, A. de Paiva, F. Lopez, A. Coutinho, M. Teixeira, E. Barbosa, E. Fonoff (São Paulo, Brazil)

1:45pm-3:15pm
Effects of subthalamic and nigral stimulation on gait kinematics in Parkinson’s disease

M. Scholten, J. Klemt, C. Plewnia, B. Bloem, F. Bunjes, R. Krüger, A. Gharabaghi, D. Weiss (Tübingen, Germany)

1:45pm-3:15pm
Efficacy and tolerability of low-frequency deep brain stimulation during daytime only in Parkinson’s disease: a pilot study

F. Dematteis, M. Zibetti, E. Montanaro, L. Rizzi, M. Lanotte, L. Lopiano, M. Rizzone (Torino, Italy)

1:45pm-3:15pm
Eight contacts with multiple-source current steering in pallidal deep brain stimulation for Parkinson’s disease: a non-randomized, single center, open-lavel study

K. Kimura, H. Kishida, N. Ueda, T. Kawasaki, K. Hamada, F. Tanaka (Yokohama, Japan)

1:45pm-3:15pm
Electrode Impedance as a marker for “on” and “off” states in a Deep Brain Stimulation cohort: A pilot study

W. Deeb, J. Shute, M. Okun (Gainesville, FL, USA)

1:45pm-3:15pm
Evaluating Use of the DBS Patient Programmer

D. Whitney, J. Karl, G. Pal, D. Ocegueda-Ramirez, B. Ouyang, L. Verhagen Metman (Chicago, IL, USA)

1:45pm-3:15pm
Excellent Non-motor Responses after Bilateral Subthalamic Deep Brain Stimulation in Parkinson’s Disease Patient with SNCA Duplication

J. Youn, J.W. Cho, J.-I. Lee (Seoul, Republic of Korea)

1:45pm-3:15pm
Expectations and Perceived Outcomes Following DBS for PD: A Case Series

D. Coughlin, M. Hernandez-Con, M. Pavon, M. Spindler, L. Chahine (Philadelphia, PA, USA)

1:45pm-3:15pm
Factors determining the motor outcome of STN DBS in PD patients: Evidence for Dual Actions

C. Lee, E.J. Choi, S.-C. Park, J.K. Lee (Seoul, Republic of Korea)

1:45pm-3:15pm
Feedback Controlled DBS in Parkinson’s Disease using Electrocorticography

N. Swann, C. de Hemptinne, A. Miller, W. Chen, I. Tamir, R Gilron, J. Ostrem, P. Starr (San Francisco, CA, USA)

1:45pm-3:15pm
First experience with 59 directional leads in deep brain stimulation

R. Nickl, P. Fricke, F. Steigerwald, J. Volkmann, C. Matthies (Würzburg, Germany)

1:45pm-3:15pm
GammaKnife subthalamotomy for Parkinson’s disease

t. witjas, r. carron, a. eusebio, j.p. azulay, j. regis (marseille, France)

1:45pm-3:15pm
Health related QoL as measured by the EQ-5D-5L in PD patients after DBS therapy: Preliminary results from the Product Surveillance Registry

M. Schiess, J. Krauss, J.-P. Azulay, E. Cuny, A. Lopez Rios, F. Farrokhi, S. Blond, T. Witt, C. Raftopoulos, J. Vesper, B. Van Dorn, T. Weaver, P. Konrad, S. Falowski, S. Palfi (Houston, TX, USA)

1:45pm-3:15pm
How efficient is subthalamic deep brain stimulation in reducing dyskinesia in Parkinson’s Disease?

N. Kovacs, A. Juhász, I. Balás (Pecs, Hungary)

1:45pm-3:15pm
Improvement of apraxia of eyelid opening in a patient with Parkinson’s disease following the change of the implantable pulse generator for subthalamic nucleus deep brain stimulation .

T. Kadowaki, K. Suzuki, E. Hoshiyama, T. Uchiyama, T. Shingo, K. Hirata (Mibu, Japan)

1:45pm-3:15pm
Interleaved Stimulation for Freezing of Gait in Advanced Parkinson’s Disease: A Pilot Study

R. Rajan, S. Zafer, S. Krishnan, K. Kesavapisharady, A. Kishore (Trivandrum, India, India)

1:45pm-3:15pm
Key clinical milestones 15 years and onwards after DBS-STN surgery – a retrospective analysis of patients that underwent surgery between 1993 and 2001

R. Constantinescu, B. Eriksson, Y. Jansson, B. Johnels, B. Holmberg, T. Gudmundsdottir, A. Renck, P. Berglund, F. Bergquist (Göteborg, Sweden)

1:45pm-3:15pm
Long term tremor benefit from cyst formation as a complication of DBS surgery in a patient with Parkinson’s disease

P. Morrison, I. Richard (Rochester, NY, USA)

1:45pm-3:15pm
Longitudinal changes in speech and voice functions after subthalamic stimulation in Parkinson’s disease patients

T. Tsuboi, H. Watanabe, Y. Tanaka, R. Ohdake, K. Kawabata, K. Hara, D. Nakatsubo, S. Maesawa, Y. Kajita, T. Wakabayashi, M. Katsuno, G. Sobue (Nagoya, Japan)

1:45pm-3:15pm
Maximising decrease in Dopaminergic drugs and increase in ON time following Bilateral STN DBS using constant current for Advanced Parkinsons Disease

S. SANYAL (CALCUTTA (KOLKATA), India)

1:45pm-3:15pm
Meta-analysis of mortality following Subthalamic and Pallidal deep brain stimulation for patients with Parkinson’s disease

A. Negida (Zagazig, El-Sharkia, Egypt)

1:45pm-3:15pm
Neuropsychological predictors of patient-reported cognitive outcomes following deep brain stimulation

K. Mills, K. Donohue, A. Swaminathan, J.-M. Leoutsakos, J. Brandt (Baltimore, MD, USA)

1:45pm-3:15pm
Optimising STN-DBS frequency parameters for improvement of gait with dual tasking in PD patients

R. Borgohain, R. Kandadai, R.P. Peddisetty, J. Kovvuru, S.S. Meka, R. Alagolu, M. Kannan (Hyderabad, India)

1:45pm-3:15pm
Pathological crying induced by deep brain stimulation of the subthalamic nucleus in Parkinsons’ disease

M. Wolf, M. Abdallat, C. Blahak, J. Krauss (Mannheim, Germany)

1:45pm-3:15pm
Patient characteristics vary by DBS indication in Parkinson disease patients

A. Pusso, S. Sperling, M. Harrison, F. Wooten, J. Elias, B. Shah, M. Barrett (Charlottesville, VA, USA)

1:45pm-3:15pm
Pharmaeconomic study of the treatment of advanced Parkinson’s disease.

F. VIVANCOS-MATELLANO, A. SANZ, J.U. MIRÓ, J. CADAVID, A. RUÍZ, N. SOLER (Madrid, Spain)

1:45pm-3:15pm
Postoperative Cognitive Impairment Following Deep Brain Stimulation Surgery

A. Whyte-Rayson, P. Hickey, M. Berger (Durham, NC, USA)

1:45pm-3:15pm
Postoperative delirium after deep brain stimulation surgery for Parkinson’s disease

F. Sasaki, G. Oyama, M. Ito, S. Sekimoto, R. Nakamura, T. Jo, Y. Simo, A. Umemura, N. Hattori (Tokyo, Japan)

1:45pm-3:15pm
Preoperative slowing of EEG and neurocognitive changes following subthalamic nucleus deep brain stimulation in Parkinson’s disease

Y. Higuchi, M. Yakufujiang, Y. Okahara, K. Aoyagi, M. Abe, T. Yamamoto, Y. Yamanaka, S. Hirano, Y. Iwadate (Chiba, Japan)

1:45pm-3:15pm
Probabilistic mapping of deep brain stimulation in Parkinson’s disease.

T. Dembek, J. Roediger, V. Visser-Vandewalle, L. Timmermann, M. Barbe (Cologne, Germany)

1:45pm-3:15pm
Programming deep brain stimulation in the globus pallidus internus for treatment of idiopathic Parkinson’s disease: experience at the University of Kentucky

J. Gurwell, J. Quintero, J. Lamm, J. Slevin, G. Gerhardt, C. van Horne (Lexington, KY, USA)

1:45pm-3:15pm
Quantitative measures of brain MRI as a predictive factor of cognitive outcomes after Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s disease

L. Weinkle, J. Tanabe, B. Hoyt, J. Thompson, J. Honce, O. Klepitskaya (Aurora, CO, USA)

1:45pm-3:15pm
Safe Functional MR Imaging in STN-DBS implanted Parkinson’s disease

M. Saxena, C. McIntyre, B. Walter (Cleveland, OH, USA)

1:45pm-3:15pm
Safety and tolerability of deep brain stimulation in early stage Parkinson’s disease: Five-year follow-up of medication use and adverse events

A. Currie, M. Turchan, L. Heusinkveld, S. Millan, M. Hacker, A. Molinari, C. Gill, T. Davis, P. Konrad, F. Phibbs, P. Hedera, D. Charles (Memphis, TN, USA)

1:45pm-3:15pm
Somnolence as untoward stimulation effect in subthalamic deep brain stimulation (STN DBS) for Parkinson’s disease (PD)

F. Danisi, C. Miller (Poughkeepsie, NY, USA)

1:45pm-3:15pm
Spinal cord stimulation reduces freezing of gait and improves gait in advanced Parkinson’s disease

O. Samotus, N. Kumar, S. Memar, M. Jog (London, ON, Canada)

1:45pm-3:15pm
STN DBS can temporarily improve balance disorders in Parkinson’s disease (PD) patients.

S. Szlufik, M. Kloda, I. Potrzebowska, K. Gregier, A. Friedman, A. Przybyszewski, J. Dutkiewicz, P. Habela, T. Mandat, D. Bialoszewski, D. Koziorowski (Warsaw, Poland)

1:45pm-3:15pm
Tear tumor necrosis factor-alpha levels in patients with Parkinson’s disease: The effect of deep brain stimulation

B. Kocer, S. Comoglu, H. Guven, M. Acar, G. Ozturk (Ankara, Turkey)

1:45pm-3:15pm
The battery longevity of implantable pulse generators (IPG) in Parkinson’s disease (PD) is affected by IPG model, number of previous IPG replacements and stimulation energy delivered.

S. Israeli-Korn, T. Fay-Karmon, S. Tessler, G. Yahalom, S. Benizri, H. Strauss, Z. Zibly, R. Spiegelmann, S. Hassin (Ramat Gan, Israel)

1:45pm-3:15pm
The DBS response ratio: An individual benchmark parameter of DBS quality

L. Lange, M. Reich, R. Nickl, F. Steigerwald, C. Matthies, J. Volkmann (Wuerzburg, Germany)

1:45pm-3:15pm
The non-motor symptoms in Parkinsons’s disease patients treated with STN DBS: the follow up study

M. Mencinger, M. Červek, T. Rus, G. Jakob, D. Georgiev, D. Flisar, R. Rajnar, M. Benedičič, K. Boetzel, J. Mehrkens, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

1:45pm-3:15pm
Twiddler Syndrome in Deep Brain Stimulation

N. Durmaz Celik, M. Vural, S. Ozkan (Eskişehir, Turkey)

1:45pm-3:15pm
UPDRS benefit from dual frequency DBS fields sculpted by intentionally overlapped interleaving

Y. Fernandez, D. Caputo, D. Schneider, R. Dipaola, S. Danish, E. Hargreaves (New York, NY, USA)

1:45pm-3:15pm
UPDRS III score and RS latency can determine the possible neuromodulative role of STN DBS in Parkinson’s disease (PD) patients

S. Szlufik, A. Przybyszewski, J. Dutkiewicz, P. Habela, T. Mandat, D. Koziorowski (Warsaw, Poland)

1:45pm-3:15pm
Weight Changes in STN and GPi Deep Brain Stimulation: Long Term Follow up

S. Shah, L. Almeida, A. Patterson, J. Hilliard, A. Wagle Shukla, K. Foote, M. Okun, D. Martinez-Ramirez, P. Zeilman (Gainesville, FL, USA)

« View all sessions from the 21st International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley